Advertisement

Topics

BS-Partikel GmbH Company Profile

04:49 EDT 19th June 2018 | BioPortfolio

BS-Partikel GmbH is engaged in particle synthesis, particle size fractionation, particle analysis and sales of high precision particle standards.
Knowledge, Experiences....
Because of research and development work over many years at university and industry a lot of commercially applied particulate polymer products (e.g. ion exchangers, flocculation aids, GPC/SEC column beads, etc.) could successfully be developed for very different industrial customers. This cumulated comprehensive knowledge combined with effectively improved laboratory technology resulted in highly tailor made polymer particle syntheses and fractionation procedures resulting in monodisperse particles finally.
BS-Partikel GmbH is proud being able to offer monodisperse particle standards with an excellent price/benefit ratio for different applications to all interested customers.

Attitude....
BS-Partikel GmbH is a scientifically driven company trying to give the most supporting information and particulate products you need from a neutral point of judgement. If we can't offer an appropriate solution of our own for your particulate problem we definitely will not propose any innecessary investigation or action for you to be done. So, we sometimes do recommend products of other manufacturers instead of ours if we think they can solve your specific problem significantly better.
Our main goal is to satisfy your needs. Therefore we probably do more than you expect!

We have a (small) research/development department which is permanently looking for new syntheses methods, improved particle fractionation processes and still more precise characterization methods and devices to improve our product quality in general. We also listen to our customers desires and suggestions very carefully to become better in all areas of customers needs. Especially this growing user-friendly relationship enabled us to design new interesting particulate products and services year by year.

Location

Bahnstr. 10
Wiesbaden
D-65205
Germany

Contact

Phone: 49/611/7-888-999
Fax: 49/611/97-218-44
Email: support@BS-Partikel.de


News Articles [138 Associated News Articles listed on BioPortfolio]

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

Original-Research: Medigene AG (von EQUITS GmbH): Kaufen

Original-Research: Medigene AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Medigene AG Unternehmen: Medigene AG ISIN: DE000A1X3W00 Anlass der Studie: Übernahme-Angebot Empfehlung: Kaufen Kursz...

PH-FIX Indikatorstäbchen pH 4,5-10 100 St MACHEREY-NAGEL GMBH & CO. KG

EUR 10,24Angebotsende: Samstag Apr-7-2018 11:22:08 CESTSofort-Kaufen für nur: EUR 10,24Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : PH-FIX Indikatorstäbchen pH 4,...

United Technologies Corporation: Aus Carrier und CIAT wird UTC Klimatechnik GmbH

Innerhalb der UTC Klimatechnik GmbH werden die beiden Marken als getrennte Geschäftsbereiche geführt. Die Vertriebsleitung für CIAT hat zum Jahresanfang Reinhard Kern übernommen. Der Kälteanlagen...

Medigene-Aktie: MDG1011-klinische Studie gestartet - Kursziel angehoben, kaufen!

Frankfurt am Main (www.aktiencheck.de) - Medigene-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, raten in einer aktuellen Aktienanal....

Evotec-Aktie: Neuer Celgene-Deal als Beschleuniger - Kaufenmpfehlung

Frankfurt am Main (www.aktiencheck.de) - Evotec-Aktienanalyse der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienexperten der EQUI.TS GmbH, raten in einer aktuellen Aktienanalyse wei....

Gerresheimer-Aktie: Dividendenerhöhung auch für 2018? Kaufempfehlung

Frankfurt am Main - Gerresheimer-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, nehmen in einer aktuellen Aktienanalyse die Coverage....

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

Clinical Trials [44 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [531 Associated Companies listed on BioPortfolio]

BS-Partikel GmbH

BS-Partikel GmbH is engaged in particle synthesis, particle size fractionation, particle analysis and sales of high precision particle standards.Knowledge, Experiences....Because of research and devel...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "BS-Partikel GmbH" on BioPortfolio

We have published hundreds of BS-Partikel GmbH news stories on BioPortfolio along with dozens of BS-Partikel GmbH Clinical Trials and PubMed Articles about BS-Partikel GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BS-Partikel GmbH Companies in our database. You can also find out about relevant BS-Partikel GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record